ERA

Download the full-sized PDF of Variation in in vivo prefrontal GABA, glutamate and glutamine – effects of reproductive factors, cortisol and major depressive disorderDownload the full-sized PDF

Analytics

Share

Permanent link (DOI): https://doi.org/10.7939/R3JS9HN59

Download

Export to: EndNote  |  Zotero  |  Mendeley

Communities

This file is in the following communities:

Graduate Studies and Research, Faculty of

Collections

This file is in the following collections:

Theses and Dissertations

Variation in in vivo prefrontal GABA, glutamate and glutamine – effects of reproductive factors, cortisol and major depressive disorder Open Access

Descriptions

Other title
Subject/Keyword
GABA
depression
spectroscopy
cortisol
prefrontal
menstrual
glutamate
Type of item
Thesis
Degree grantor
University of Alberta
Author or creator
Bhardwaj, Paramjit P
Supervisor and department
Coupland, Nicholas (Psychiatry)
Le Melledo, Jean-Michel (Psychiatry)
Examining committee member and department
MacMaster, Frank (Psychiatry)
Hanstock, Chris (Biomedical Engineering)
Baker, Glen (Psychiatry)
Fujiwara, Esther (Psychiatry)
Department
Department of Psychiatry
Specialization
Psychopharmacology
Date accepted
2017-09-08T11:53:52Z
Graduation date
2017-11:Fall 2017
Degree
Doctor of Philosophy
Degree level
Doctoral
Abstract
Variations in glutamate and γ-aminobutyric acid (GABA), excitatory and inhibitory amino acid neurotransmitters in the brain, have been linked with cyclical changes across the menstrual cycle and in stress and stress-related mental disorders. We used 3.0 Tesla proton magnetic resonance spectroscopy (1H-MRS) to investigate GABA+ levels (GABA + macromolecules) in the anterior cingulate/prefrontal cortex (ACC) in relation to menstrual cycle phase and the use of hormonal birth control and in a case-control comparison of patients with major depressive disorder (MDD) and healthy matched controls. We measured ACC GABA+ using a double quantum filter with selective dual band refocusing, a method that is more selective for GABA+ than the commonly used J-difference editing method. We did not confirm the hypothesis that ACC GABA+ would decrease between the follicular (1.12 ± .30 mmol/L) and late luteal phase (1.05 ± .31 mmol/L) of the menstrual cycle (n = 20; paired t = 1.28; df = 19; p = 0.22). ACC GABA+ levels did not differ between women in the follicular phase of the menstrual cycle (n = 16; 1.11 ± .27 mmol/L) and those in the first week of pill-use of hormonal birth control (n = 14; 1.08 ± .19 mmol/L; t = 0.39; df = 28; p = 0.70). We did not confirm the hypothesis that ACC GABA+ would be lower in patients with MDD (n = 35; 1.04 ± 0.31 mmol/L) than in healthy controls (n = 42; 1.11 ± 0.22; t = 1.24; df =75; 1-tailed p = 0.11). In a post hoc analysis, MDD patients with the most severe depressive anhedonia showed lower ACC GABA+ levels (0.98 ± 0.05 mmol/L; F1,58; p = 0.04) than controls. Strengths of the GABA studies include improved measurement selectivity, quantification of ACC GABA+ with respect to brain water and the largest sample sizes for these investigations to date. The main limitation was that the quantification method did not provide estimates of fitting precision. 1H-MRS was also used to study the acute (within 30 minutes) and delayed (48 hours) effects of the administration of cortisol (40-100 mg) on glutamate and glutamine in healthy volunteers, in a double-blind, randomized, placebo-controlled design. We measured glutamate and glutamine separately, using spectrally-selective refocusing acquisitions. The administration of cortisol 40 mg (n = 6) or 100 mg (n = 8) did not lead to significant acute or delayed changes in glutamate or glutamine levels compared with placebo (n = 5). Strengths of the cortisol study were the selective measurements of glutamate and glutamine and their quantification with respect to brain water, using LCModel analysis. A major weakness was that the sample size was under-powered to test hypotheses definitively. The selective measurement of GABA+ and glutamine using 1H-MRS is technically challenging, particularly for the ACC region that was studied. The current study of MDD adds to evidence that differences in ACC GABA+ may only be large enough to be detectable in more severely ill patients.
Language
English
DOI
doi:10.7939/R3JS9HN59
Rights
This thesis is made available by the University of Alberta Libraries with permission of the copyright owner solely for the purpose of private, scholarly or scientific research. This thesis, or any portion thereof, may not otherwise be copied or reproduced without the written consent of the copyright owner, except to the extent permitted by Canadian copyright law.
Citation for previous publication

File Details

Date Uploaded
Date Modified
2017-09-08T17:53:54.419+00:00
Audit Status
Audits have not yet been run on this file.
Characterization
File format: pdf (Portable Document Format)
Mime type: application/pdf
File size: 2075566
Last modified: 2017:11:08 16:53:34-07:00
Filename: Bhardwaj_Paramjit_P_201708_PhD.pdf
Original checksum: 15d8d7f716a7ccc5d9945d85502751f4
Well formed: false
Valid: false
Status message: Invalid page tree node offset=828572
Status message: Unexpected error in findFonts java.lang.ClassCastException: edu.harvard.hul.ois.jhove.module.pdf.PdfSimpleObject cannot be cast to edu.harvard.hul.ois.jhove.module.pdf.PdfDictionary offset=3218
Page count: 100
Activity of users you follow
User Activity Date